viernes, 8 de julio de 2022

NRG Oncology study of atezolizumab and chemoradiation for patients with limited-stage small cell lung cancer completes accrual

NRG Oncology study of atezolizumab and chemoradiation for patients with limited-stage small cell lung cancer completes accrual

No hay comentarios:

Publicar un comentario